JPRN-UMIN000043798
Recruiting
N/A
Exploratory study of biomarkers for therapeutic efficacy and immune-related adverse events of immune checkpoint inhibitors - Biomarkers of immune checkpoint inhibitors
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- All cancer types indicated for immune checkpoint inhibitor
- Sponsor
- Kumamoto University
- Enrollment
- 400
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •The patient whom the researcher consider to be inappropriate for the study.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
N/A
Search of biomarkers related to the therapeutic effect of sublingual immunotherapy with epigenome analysisJapanese cedar pollinosisJPRN-UMIN000023910ippon Medical School50
Completed
N/A
Exploratory study for biomarkers to predict efficacy and toxicity to Sorafenib in patients with advanced hepatocellular carcinomaHepatocellulara carcinomaJPRN-UMIN000008808ational Cancer Center Hospital100
Not Yet Recruiting
N/A
Exploratory research of biomarkers for investigational drugs using tear fluid samplesJPRN-UMIN000049186Santen Pharmaceutical Co. Ltd.29
Recruiting
N/A
Prospective study of biomarkers and pharmacological characteristics for patients with metastatic lung tumorsmetastatic lung tumorJPRN-UMIN000053045Keio University550
Recruiting
N/A
Investigation of biomarkers for diagnosis and treatment of pulmonary hypertension.Pulmonary hypertensionJPRN-UMIN000032888Juntendo University50